在高血压的首要预防. 从观察性研究中得出的有效结论
A W Hoes1, D E Grobbee, J Lubsen
1Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
Circulation
|December 1, 1991
概括
对抗高血压药物用于冠心病的初级预防的观察性研究是有限的. 现有数据表明β-阻断剂可能提供更好的保护,但需要更多的研究.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 有限的观察性研究存在于抗高血压药物治疗,用于冠心病 (CHD) 的初级预防.
- 确保内部有效性,特别是避免通过指示混,对于这一领域的观察性研究至关重要.
研究的目的:
- 审查观察性研究在评估抗高血压药物对初级心血管疾病预防有效性的作用和挑战.
- 与随机试验相比,突出观察性设计的潜在优势和局限性.
主要方法:
- 现有关于抗高血压治疗和初级心血管疾病预防的观察性研究 (随访和病例控制) 的审查.
- 讨论在非随机化研究中确保内部有效性和可比性的方法考虑.
主要成果:
- 关于这个话题,很少有高质量的观察性研究发表.
- 初步发现表明β阻塞剂可能与其他抗高血压疗法相比,对首次心血管疾病事件提供更好的保护.
结论:
- 观察性研究可以为抗高血压疗法提供宝贵的见解,用于初级心血管疾病预防.
- 鉴于观测设计的内在潜力和陷,这是它们在这个研究领域有效使用的关键.
- 需要进一步进行强有力的观察性研究,以确认特定药物类 (如β-阻断剂) 的潜在益处.
更多相关视频
相关概念视频
Factors affecting Blood pressure
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...


